EVI
AMEX · Trading Companies & Distributors
Evi Industries Inc
$16.39
+0.12 (+0.74%)
EVI News30 articles
Capricor Shares Jump as FDA Reviews New Duchenne Data; PDUFA Date Looms
Capricor shares rose 51.7% after the FDA agreed to review new 24-month data for deramiocel, but the stock remains far below its July peak as the Aug. 22 decision date approaches.
Boeing Shares Slip as Ryanair Probe Reveals Bird Strike Evidence
Boeing (BA) shares dipped 0.4% after investigators found bird debris and broken fan blades in a Ryanair 737 engine, highlighting a $2 billion market value shortfall versus the broader market.
Quanterix Plunges 39% on Revised Guidance, Delayed Breakeven
Quanterix (QTRX) dropped 39% after lowering 2026 revenue guidance and delaying cash-flow breakeven to 2027. Q2 revenue rose 34% but margins were mixed.
Palo Alto Networks Holds Steady Amid China Review, Valuation Scrutiny
Palo Alto Networks (PANW) shares ended the week up 9.7% despite a China review, with analysts focusing on underlying growth and valuation concerns.
MP Materials Q2 Preview: Price Support Dominates Earnings Outlook
MP Materials (NYSE:MP) reports Q2 earnings Thursday with Q1 price-protection income topping EBITDA. Analysts expect a loss despite surging NdPr sales.
Disney Q3 earnings preview: Parks must offset sports slump
Disney (NYSE:DIS) faces a key earnings test Wednesday. Analysts expect 15.5% EPS growth, but sports profits are set to fall 14%, putting pressure on Parks and Entertainment to deliver.
Inno Holdings Stock Plunges 54% on Share-Count Revision
Inno Holdings shares plunged 54% after trading resumed, as a revised share count implies a $45M valuation, below its $60M ATM program ceiling.
Grab's Q2 Earnings Preview: Fintech Growth and Margin Concerns
Grab's Q2 report looms as fintech margins and loan growth face scrutiny. Revenue is projected near $1 billion, with financial services driving sequential growth.
AMC Stock Slips Despite Record Spider-Man Preview and Dilution Concerns
AMC shares dipped to $2.76 despite a record $72M Spider-Man preview. A 74% increase in share count weighs on valuation.
Vertiv Rebounds as Revised Forecast Pushes H2 Revenue Target to $8.08B
Vertiv shares climb 4.9% in premarket after a 17.3% drop, as a raised full-year outlook requires an additional $326 million in H2 sales.
Robinhood Q2 Preview: Profitability Questions Loom Over Event-Contract Growth
Robinhood shares fell 2.6% ahead of Q2 results, with attention turning to event contracts as crypto revenue slumps and profitability concerns mount.
Amazon Earnings Preview: AWS Profitability Squeeze Amid $200B Spending Plan
Amazon's Q2 earnings preview shows AWS revenue growth of 31% but a 390 bps margin drop, squeezing operating income. A $200 billion capex plan adds cash-flow concerns.
Archer Aviation Holds $390M Gain After Q2 Earnings Preview
Archer Aviation closed Monday with an estimated $390 million gain, up 3.8% to $4.95, ahead of Q2 earnings on August 10.
Teva Q2 Preview: Emalex Charge May Mask Underlying Progress
Teva's Q2 results face a $700M Emalex charge that could neutralize branded-drug growth, with consensus EPS near zero. Revenue is forecast at $4.058B.
Wearable Devices Shares Surge on Massive Trading Volume
Wearable Devices Ltd. saw its stock price surge 50.7% on Thursday, with trading volume reaching 11.5 times the total share count. Premarket activity remains elevated.
Intel Q2 Earnings Preview: AI Server Demand, Margin Focus
Intel's Q2 earnings report is expected to show strong AI-driven revenue growth, with the Data Center and AI segment forecast to grow 36.4%.
Infosys Q1 Preview: Organic Growth Stalls as Stock Lags Nifty IT
Infosys shares have underperformed the Nifty IT index ahead of Q1 results due Thursday. Early projections show organic sequential growth near 1%, with acquisitions providing a tailwind.
Huntington Bancshares Q2 Preview: Deal-Driven Growth Meets EPS Expectations
Huntington Bancshares (HBAN) closes up 0.6% ahead of Q2 earnings, with analysts eyeing deal-driven EPS growth amid integration costs and margin pressures.
IREN Shares Rise on AI Cloud Prepayment Deals Alleviating Funding Worries
IREN shares rose 5.7% premarket after $2.8B in AI cloud contracts with 45% prepayments eased GPU funding concerns, lifting 2026 ARR target to over $4B.
Alibaba Unveils Qwen3.8-Max-Preview AI Model Amid Apple Partnership Hopes
Alibaba (BABA) introduced Qwen3.8-Max-Preview on Sunday, a 2.4 trillion parameter AI model. ADRs ended the week up 2.35% after an Apple approval surge, but half of Wednesday's gains were lost by Friday's close.
Pentagon Review Freezes $47B Onshore Wind Pipeline Amid State Opposition
A Pentagon review halt has frozen $47 billion in onshore wind projects, affecting 106 developments and nearly 30 GW of capacity across 21 states.
Nvidia Lags Chip Sector by 65 Points Amid Stricter Asia Sales Reviews
Nvidia shares are underperforming the broader chip index by over 65 points as tighter sales reviews in Asia raise concerns about revenue growth.
Netflix Q2 Preview: $8.1B H2 Profit Target Sparks Investor Scrutiny
Netflix heads into Q2 earnings with an $8.1 billion second-half profit target, a 30% year-over-year jump. Investors will scrutinize margins, ad revenue, and engagement data.
Transocean-Valaris Deal Spread Narrows to 2.1% as Antitrust Review Lengthens
Transocean (RIG) shares imply a 2.1% discount to Valaris (VAL) in their all-stock merger, with the spread narrowing slightly as the deal faces a longer antitrust review and a target close of September 29.
ITW Shares Revisit Buyback Price as Earnings Test Looms
ITW shares closed near the average price paid in March's buyback, but underperformed the S&P 500 last week. The stock's 23.8x forward P/E raises stakes for the July 28 earnings report.
Levi Strauss Stock Dips After Earnings Beat, Tariff Concerns Loom
Levi Strauss shares slipped after-hours despite topping Q2 estimates and raising its full-year guidance, as investors focused on tariff exposure and uneven demand.
Agios Pharmaceuticals Jumps on FDA Priority Review for Sickle Cell Drug
Agios Pharmaceuticals shares jumped 14.9% after the FDA accepted its mitapivat application for sickle cell disease with Priority Review, setting a Nov. 1 PDUFA date.
Netflix Surges 4.6% Before July 4 Break, Earnings Preview in Focus
Netflix shares surged 4.66% to $77.65 on Thursday, with volume 134% above average, ahead of the July 4 holiday. The stock rebounded but remains well below 52-week highs.
AtkinsRéalis Surges on Turkey Nuclear Review, Market Cap Gains C$683M
AtkinsRéalis shares surged 4.81% as Turkey's preliminary review of CANDU reactors boosted investor sentiment, adding C$683 million in market cap.
Crypto-Backed Lending Revival: Wall Street Banks Lead as Bitcoin Nears $60K
Crypto-collateralized lending surged 49% year-over-year to $67 billion in Q1 2026, with Wall Street banks replacing failed crypto lenders. Bitcoin hovered near $59,400.